Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma (Q33907171)

29 July 2017

title

Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma (English)

1 reference

29 July 2017

Sanja Stifter

1

1 reference

29 July 2017

Emina Babarović

2

1 reference

29 July 2017

Toni Valković

3

1 reference

29 July 2017

Irena Seili-Bekafigo

4

1 reference

29 July 2017

Christophe Stemberger

5

1 reference

29 July 2017

Antica Nacinović

6

1 reference

29 July 2017

Ksenija Lucin

7

1 reference

29 July 2017

Nives Jonjić

8

1 reference

29 July 2017

publication date

18 May 2010

1 reference

29 July 2017

1 reference

29 July 2017

volume

5

1 reference

29 July 2017

page(s)

30

1 reference

Options for histological examination of bone marrow during diagnosis of multiple myeloma

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883968

Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883968

Plasma cell quantification in bone marrow by computer-assisted image analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883968

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883968

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883968

Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883968

Prognostic significance of plasma cell morphology in multiple myeloma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883968

Plasma cell tumours: cytomorphological features in a series of 12 cases diagnosed on fine needle aspiration cytology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883968

Prognostic significance of bone marrow histology in multiple myeloma.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883968

Audit of bone marrow aspirates and trephine biopsies in multiple myeloma--a single centre study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883968

Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883968

Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2883968

Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation

29 October 2018

1 reference

12 December 2020

Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patients with multiple myeloma

1 reference

12 December 2020

Bone marrow plasma cell microaggregates detected by immunohistology predict earlier relapse in patients with minimal disease after high-dose therapy for myeloma

1 reference

12 December 2020

Histomorphology of multiple myeloma on bone marrow biopsy

1 reference

12 December 2020

The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells

1 reference

12 December 2020

[Diagnostic importance and pitfalls of evaluating bone marrow smear preparation in multiple myeloma]

1 reference

12 December 2020

Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients

1 reference

12 December 2020

CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies

1 reference

12 December 2020

The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens

1 reference

12 December 2020

Bone marrow evaluation: the relative merits of particle sections and smear preparations

1 reference

12 December 2020

Comparison of the usefulness of bone marrow sections and smears in diagnosis of multiple myeloma

1 reference

12 December 2020

Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin

1 reference

12 December 2020

Identifiers

DOI

10.1186/1746-1596-5-30

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference